SUBSCRIBE TODAY!
Subscribing entitles a reader to complete stories on all topics released as they happen, special features, confidential documents and access to the complete, searchable story archive online back to 2004.
IP-Watch Summer Interns

IP-Watch interns talk about their Geneva experience in summer 2013. 2:42.

Inside Views

Submit ideas to info [at] ip-watch [dot] ch!

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

Quantitative Analysis Of Contributions To NETMundial Meeting

A quantitative analysis of the 187 submissions to the April NETmundial conference on the future of internet governance shows broad support for improving security, ensuring respect for privacy, ensuring freedom of expression, and globalizing the IANA function, analyst Richard Hill writes.


Latest Comments
  • Why should anyone care what James Anaya thinks? In... »
  • If this goes ahead, as the EU will "speak" for all... »

  • For IPW Subscribers

    A directory of IP delegates in Geneva. Read more>

    A guide to Geneva-based public health and intellectual property organisations. Read More >


    Monthly Reporter

    The Intellectual Property Watch Monthly Reporter, published from 2004 to January 2011, is a 16-page monthly selection of the most important, updated stories and features, plus the People and News Briefs columns.

    The Intellectual Property Watch Monthly Reporter is available in an online archive on the IP-Watch website, available for IP-Watch Subscribers.

    Access the Monthly Reporter Archive >

    WHO

    17/07/2013: People: Transitions In The Global IP Community
    11/07/2013: WHO Priority Medicines Report Sees Drop In R&D Productivity
    10/07/2013: “Trilateral” Symposium Addresses Topics Of Global Public Health And IP
    08/07/2013: WHO, WTO, WIPO Heads Call For More Medical Innovation
    03/07/2013: Special Feature: A Look At Product Development Partnerships And Innovation For Neglected Diseases
    02/07/2013: MSF: Prices On Latest ARV Drugs Under Patent Too High
    30/06/2013: WHO Issues Guidelines To Push HIV Epidemic Into “Irreversible Decline”
    26/06/2013: Medicines Patent Pool Signs New Licence Agreements
    26/06/2013: UNAIDS Reports Sharp Drop In New HIV Infections In Some African Countries
    25/06/2013: WHO Wrestles With Engagement Of “Non-State Actors”
    24/06/2013: WHO Restructures Medicines Department, Including Innovation, Policy
    19/06/2013: The Impact Of Derailing The WHO Medical R&D Convention
    19/06/2013: WIPO Seminar Discusses Impact Of TRIPS On Pharmaceutical Innovation
    17/06/2013: Group Of Experts Looks At High Price Of Cancer Drugs
    14/06/2013: WIPO-WTO-WHO Joint Symposium On Medical Innovation In July
    13/06/2013: WHO Updates Guidance For Pandemic Flu Risk Management
    12/06/2013: Geneva Study Finds ‘Evergreening’ Increases Healthcare Costs
    05/06/2013: Author Cites Persistent Tobacco Industry Attempts To Influence WHO
    05/06/2013: Data From Clinical Trials Identify Gaps In Health R&D
    28/05/2013: World Health Assembly: IP Considerations Play Key Role In Final Outcomes
    27/05/2013: World Health Assembly: As Members Approve Health R&D Decisions, US Says Time To “Put Our Money Where Our Mouth Is”
    27/05/2013: World Health Assembly: Pandemic Flu Framework Clears Committee
    27/05/2013: Inside Views: Focus On Quality For Patients Saves Billions Of Dollars
    26/05/2013: World Health Assembly: Committee Breaks Deadlock On Poor Quality Meds Mechanism
    25/05/2013: World Health Assembly: Drafting Group Agrees On Health R&D Meeting Proposal
    24/05/2013: World Health Assembly: Members Debate US Proposed Advisory Meeting On Health R&D
    24/05/2013: Inside Views: WHO Should Have The Evidence? Ben Goldacre Refutes WHO Director’s Claim
    24/05/2013: World Health Assembly: Groups Seek To Return Focus To ‘Broken’ Medical R&D System
    23/05/2013: World Health Assembly: Draft Of NCD Action Plan Shows Compromises On IPRs
    22/05/2013: World Health Assembly: Drafting Group Progressing On NCDs
    20/05/2013: WHO Director Highlights Noncommunicable Diseases, Pandemics; Blasts Industry Counter-Efforts
    20/05/2013: Conference On Journalism And Health Looks At WHA Issues
    17/05/2013: World Health Assembly: R&D, NCDs, Pandemics Top Agenda
    15/05/2013: WHO Stats Show Medicines Remain Out Of Reach Of Poorest Patients
    01/05/2013: Experts Offer Perspectives On R&D Policies In The Public Health Domain
    24/04/2013: Inside Views: Global Public-Private Partnerships Against IP Crimes: How Interpol Avoided The Failures Of WCO And WHO
    22/04/2013: Curbing Vaccine Costs Key To Extending Global Immunisation Reach
    10/04/2013: Study: Misuse Of Patent System Affecting Health System In Australia
    04/04/2013: Linguistic Diversity Essential For Innovation, Development, Roundtable Speakers Say
    03/04/2013: Australian Pharmaceutical Patents Review Draft Report Critical Of Patent Extensions, R&D Funding
    19/03/2013: Pharma, International Red Cross Combine To Fight NCDs
    18/03/2013: Tuberculosis: WHO, Global Fund Call For Mobilisation Of Funds As Resistance Rises
    04/03/2013: Patent Pool-ViiV Collaboration On Paediatric HIV Sparks Reactions, Hope
    28/02/2013: Global Health Giants, Trade Deals, And IP Play Central Role In 2013 Public Health Policy
    27/02/2013: WIPO Members Struggle To Define Work Programme On Patents And Health
    15/02/2013: UN Takes On Organised Crime And Fraudulent Medicines
    11/02/2013: Report Proposes Solutions To Address Noncommunicable Diseases
    07/02/2013: People: Tracking IP Influencers’ Latest Moves
    06/02/2013: WHO, WTO, WIPO Provide Policymakers Policy Options For Public Health
    03/02/2013: Polio Talks At WHO Board: Between Progress Made, The Final Push And The Role Of Partnership
    Your IP address is 54.196.23.239